Circulating nucleic acids as diagnostic biomarker of cancer diseases

Authors

  • O. V. Bulgakova L.N. Gumilyov Eurasian National University, Kazakhstan, Astana
  • A. Zh. Kausbekova L.N. Gumilyov Eurasian National University, Kazakhstan, Astana
  • R. I. Bersimbaev L.N. Gumilyov Eurasian National University, Kazakhstan, Astana

DOI:

https://doi.org/10.26577/eb-2018-1-1316

Abstract

In the last decade, one of the most important trends of modern science is the search of the biomarkers, which would have high sensitivity and specificity for non-invasive diagnostics of cancer diseases. Immunological methods are not a well established practice in cancer diagnostics because of low specificity of currently used tumor markers.

The study of free - circulating nucleic acids in plasma and serum of cancer patients represents a promising direction of modern molecular diagnostics.

Free - circulating nucleic acids include DNA, RNA, microRNA, viral DNA / RNA and mitochondrial DNA. In this case, free-circulating nucleic acids can be present both in the free form and in the supramolecular nucleoprotein complexes.

However, many aspects related to the biogenesis of free-circulating nucleic acids, as well as their role in the mechanism of carcinogenesis, are still not clear.

This review focuses on the biological properties of free - circulating nucleic acids, biogenesis, their role in the pathogenesis of cancer and the possibility of using free - circulating nucleic acids as biomarkers in the diagnosis of cancer.

Key words: free circulating nucleic acids, free circulating DNA, microRNA, mitochondrial DNA, cancer, biomarkers.

Downloads

Published

2018-07-14

Issue

Section

МOLECULAR BIOLOGY AND GENETICS

How to Cite

Circulating nucleic acids as diagnostic biomarker of cancer diseases. (2018). Experimental Biology, 74(1), 62-73. https://doi.org/10.26577/eb-2018-1-1316

Most read articles by the same author(s)